G2TT
来源类型Report
规范类型报告
DOIhttps://doi.org/10.7249/RR4445
来源IDRR-4445-OSD
Balancing Access and Cost Control in the TRICARE Prescription Drug Benefit
Andrew W. Mulcahy; Brian Phillips; Christopher M. Whaley
发表日期2021-01-14
出版年2021
页码24
语种英语
结论
  • TRICARE could realize significant savings by steering prescribers and patients to generic alternatives within broader therapeutic classes.
  • There is broad overlap in the classes of drugs used in TRICARE and the Veterans Health Administration (VHA). Increased formulary and acquisition harmonization between TRICARE and the VHA could lead to cost savings.
  • Adopting TRICARE's narrower specialty pharmacy network for all prescription drugs would allow for further price reductions through lower dispensing fees, although the trade-offs between savings and access would have to be carefully studied.
  • The U.S. Department of Defense (DoD) should take full advantage of lower prices when drugs are acquired directly by DoD. DoD should explore whether it is possible to dispense directly acquired drugs (when purchased at unit prices) through retail pharmacies and to shift specialty drug dispensing and administration to military treatment facilities under TRICARE's medical benefit.
摘要

The Military Health System provides health coverage — including prescription drug benefits — through the TRICARE program, which served an estimated 9.5 million beneficiaries in fiscal year 2018. Like commercial insurance and other sources of drug coverage, TRICARE uses formularies and other policies and tools to strike a balance between access to prescription drugs — in terms of which drugs are covered and where enrollees can receive drugs — and spending. Spending on prescription drugs typically increases as drug access becomes more generous. Unlike other sources of prescription drug coverage, TRICARE must also balance direct acquisition and distribution of drugs via military treatment facilities and mail-order pharmacies with payment for drugs dispensed in retail pharmacies. This report describes the TRICARE pharmacy benefit and the trade-offs in TRICARE pharmacy policies between increasing access and controlling costs. It presents six approaches that TRICARE should explore further to improve access, control costs, or both, including a more selective formulary, narrower pharmacy networks, and further harmonization with other federal purchasers, such as the Veterans Health Administration (VHA). These approaches are worth exploring in light of the recompetition of the TRICARE pharmacy contract and the ongoing consolidation of authority and management for purchased care under the Defense Health Agency.

目录 Balancing Access and Cost Control in the TRICARE Prescription Drug Benefit | RAND
主题Defense Health Agency ; Health Care Costs ; Pharmaceutical Drugs ; Prescription Drug Benefits ; Veterans Health Care
URLhttps://www.rand.org/pubs/research_reports/RR4445.html
来源智库RAND Corporation (United States)
引用统计
资源类型智库出版物
条目标识符http://119.78.100.153/handle/2XGU8XDN/524333
推荐引用方式
GB/T 7714
Andrew W. Mulcahy,Brian Phillips,Christopher M. Whaley. Balancing Access and Cost Control in the TRICARE Prescription Drug Benefit. 2021.
条目包含的文件
文件名称/大小 资源类型 版本类型 开放类型 使用许可
RAND_RR4445.pdf(354KB)智库出版物 限制开放CC BY-NC-SA浏览
x1610628547938.jpg.p(4KB)智库出版物 限制开放CC BY-NC-SA浏览
个性服务
推荐该条目
保存到收藏夹
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Andrew W. Mulcahy]的文章
[Brian Phillips]的文章
[Christopher M. Whaley]的文章
百度学术
百度学术中相似的文章
[Andrew W. Mulcahy]的文章
[Brian Phillips]的文章
[Christopher M. Whaley]的文章
必应学术
必应学术中相似的文章
[Andrew W. Mulcahy]的文章
[Brian Phillips]的文章
[Christopher M. Whaley]的文章
相关权益政策
暂无数据
收藏/分享
文件名: RAND_RR4445.pdf
格式: Adobe PDF
文件名: x1610628547938.jpg.pagespeed.ic.o9ptZIrm_9.jpg
格式: JPEG

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。